© 2019 Bruder Consulting & Venture Group, All Rights Reserved.  New York, United States

Please reload

Recent Posts

Dr. Scott Bruder to Lecture on Selection of Appropriate Clinical Targets for Regenerative Medicine at the 4th Annual Mid-Atlantic Advanced Biomanufact...

August 30, 2019

1/3
Please reload

Featured Posts

AnGes Announces FDA Clearance of Investigational New Drug (IND) Application for NF-kappaB Decoy Oligo DNA to Treat Discogenic Lower Back Pain

April 25, 2017

Read the article here

 

 

Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags